相关实验视频
Updated: Jul 22, 2025

05:18
Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment
Published on: November 22, 2024
628
在III类肥胖患者中使用标准剂量的阿齐思罗米辛,这些患者接受了非计划的剖腹产分娩
Maeve K Hopkins1, Surabhi Tewari2, Meng Yao3
1Division of Maternal and Fetal Medicine, Obstetrics and Gynecology Institute, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio.
American journal of perinatology
|July 24, 2023
概括
标准剂量的阿齐思罗米预防显著减少了剖腹产伤口并发症和非计划的产后访问在III类肥胖患者. 这一发现突出了阿齐思罗米的重要性.
科学领域:
- 产科和妇科 产科和妇科
- 手术部位感染的预防 手术部位感染的预防
- 药理学 药理学是指药理学的学科.
背景情况:
- 剖腹产伤口并发症是一个重大问题,特别是在患有III类肥胖症 (BMI ≥40 kg/m2) 的患者中.
- 术后抗生素预防是减少手术部位感染的标准,但其在高风险肥胖人群中的有效性需要进一步调查.
研究的目的:
- 评估将标准剂量 (500毫克) 的阿齐思罗米辛预防整合到非预定剖腹产的III类肥胖患者的外科护理中的影响.
- 确定这种干预措施是否能减少产后伤口并发症的发生率.
主要方法:
- 进行了一项回顾性队列研究,比较阿齐思罗米在医院订单集中整合之前和之后的患者 (2017年1月 - 2020年1月).
- 分析了结局,包括复合性伤口并发症 (血清瘤,血瘤,感染) 在整合前和后组之间.
- 统计分析比较了并发症的发生率,并确定了阿齐思罗米给药的影响.
主要成果:
- 整合后队列 (970名患者) 与整合前队列 (303名患者) 相比,复合性伤口并发症的发生率显著降低 (7.9%与13.9%,p=0.002).
- 在整合后的组中观察到较低的表面或深层伤口感染率 (6.7%与10.2%,p=0.042) 和减少的再接收/非计划访问 (18.7%与24.4%,p<0.029).
- 标准剂量的阿齐思罗米与术后伤口并发症的风险降低有关 (OR:0.67,CI:0.46-0.99,p=0.043).
结论:
- 标准剂量的阿齐思罗米是一种有效的外科手术期间预防药物,用于接受剖腹产的III类肥胖患者.
- 这种干预措施显著降低了剖腹产后伤口并发症的发生率和非计划产后护理的需要.
- 整合阿齐思罗米预防是一种有价值的策略,可以改善这一高风险产科人群的结果.
相关概念视频
Peptic Ulcer Disease IV: Management
110
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
110
Drugs for Treatment of Constipation-Predominant IBS
213
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
213
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
119
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
119
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
158
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
158
Drugs for Treatment of Diarrhea-Predominant IBS
214
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
214
Dosage Regimen: Fixed Dose
1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K

